Keywords: Osteomyelitis; Telavancin; Outpatient parenteral antimicrobial therapy; Lipoglycopeptide;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Telavancin; S. aureus; Lipoglycopeptide; Complicated skin and skin-structure infection;
Keywords: Telavancin; Osteomyelitis; Gram-positive; S. aureus; Surveillance;
Keywords: Telavancin; Vancomycin; MRSA; Cancer patients; Time-kill; Bactericidal activity;
Keywords: Staphylococcus aureus; MRSA; Vancomycin; Ceftaroline; Daptomycin; Dalbavancin; Telavancin; Tedizolid;
Keywords: Biofilm; Staphylococcal; Telavancin
Keywords: Gram-positive infections; Hospital-acquired pneumonia; MRSA; Nosocomial pneumonia; Telavancin;
Keywords: acute bacterial skin and skin structure infections; dalbavancin; oritavancin; telavancin;
Effective Antimicrobial Stewardship Strategies for Cost-effective Utilization of Telavancin for the Treatment of Patients With Hospital-acquired Bacterial Pneumonia Caused by Staphylococcus aureus
Keywords: cost-effectiveness; hospital-acquired pneumonia; lipoglycopeptide; modeling; stewardship; telavancin;
Telavancin for the treatment of methicillin-resistant Staphylococcus aureus bone and joint infections
Keywords: Bone; Prosthetic joint; MRSA; Osteomyelitis; Telavancin;
Chemical Stability of Telavancin in Elastomeric Pumps
Keywords: antibiotic; elastomeric; outpatient; parenteral; stability; telavancin
Post-reconstitution Stability of Telavancin with Commonly Used Diluents and Intravenous Infusion Solutions
Keywords: telavancin; reconstitution; stability; intravenous; infusion
Quantitative determination of telavancin in pregnant baboon plasma by solid-phase extraction and LC–ESI–MS
Keywords: Telavancin; LC–ESI–MS; SPE; Baboon plasma
Telavancin activity tested against a contemporary collection of Gram-positive pathogens from USA Hospitals (2007-2009)
Keywords: Telavancin; Lipoglycopeptide; Staphylococcus aureus; Gram-positive; USA;
Transplacental transfer of vancomycin and telavancin
Keywords: methicillin-resistant Staphylococcus aureus; pregnancy; telavancin; transplacental transfer; vancomycin;
In vitro activity of telavancin and comparator antimicrobial agents against a panel of genetically defined staphylococci
Keywords: Staphylococcus aureus; Telavancin; In vitro activity
Update on the telavancin activity tested against European staphylococcal clinical isolates (2009–2010)
Keywords: Telavancin; Lipoglycopeptide; Staphylococcus spp.; Glycopeptides; Europe
Effect of telavancin on human intestinal microflora
Keywords: Telavancin; Human intestinal microflora; Ecological impact
In vitro activity of dalbavancin and telavancin against staphylococci and streptococci isolated from patients in Canadian hospitals: results of the CANWARD 2007–2009 study
Keywords: Dalbavancin; Telavancin; Vancomycin
In vitro activity of telavancin against Gram-positive isolates from complicated skin and skin structure infections: results from 2 phase 3 (ATLAS) clinical studies
Keywords: Telavancin; Vancomycin; Susceptibility; Clinical trial; Skin infection; Staphylococcus aureus; MRSA;
Activity of telavancin and comparator antimicrobial agents tested against Staphylococcus spp. isolated from hospitalised patients in Europe (2007–2008)
Keywords: Telavancin; Lipoglycopeptide; Staphylococcus spp.; Surveillance; Europe
Worldwide summary of telavancin spectrum and potency against Gram-positive pathogens: 2007 to 2008 surveillance results
Keywords: Telavancin; Staphylococcus aureus; Lipoglycopeptide; Gram-positive
Evaluation of daptomycin, telavancin, teicoplanin, and vancomycin activity in the presence of albumin or serum
Keywords: Protein binding; Antimicrobial effect; Daptomycin; Telavancin; Teicoplanin; Vancomycin
New antibiotic agents for bloodstream infections
Keywords: Bloodstream infections; Daptomycin; Linezolid; Quinupristin/dalfopristin; Tigecycline; Dalbavancin; Telavancin; Oritavancin; Ceftobiprole; Doripenem; Colistin; Antibiotic lock therapy; Continuous intravenous antibiotic administration